{"disease":{"id":"neuropathic-diabetic-ulcer-foot","name":"Neuropathic diabetic ulcer - foot","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"becaplermin","indication_name":"Neuropathic diabetic ulcer - foot","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Regranex","generic_name":"BECAPLERMIN","company_name":"Omj Pharmaceuticals","drug_phase":"marketed","molecular_target":"Platelet-derived growth factor receptor","drug_class":"Human Platelet-derived Growth Factor","quality_score":21,"revenue":null,"mechanism":""},{"drug_id":"regranex","indication_name":"Neuropathic diabetic ulcer - foot","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Regranex","company_name":"Solsys Medical LLC","drug_phase":"marketed","molecular_target":"Platelet-derived growth factor receptor","drug_class":"","quality_score":13,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06889038","title":"Hyperbaric Oxygen Therapy Combined With Polarized Light Therapy Effect on Neuropathic Foot Ulcer","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Al-Zaytoonah University of Jordan","has_results":false},{"nct_id":"NCT04186377","title":"Application of S26E for Diabetic Foot Ulcer Healing","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"National and Kapodistrian University of Athens","has_results":false},{"nct_id":"NCT07222540","title":"Expanded Access Program Evaluating SkinTE in the Treatment of Wagner 1 Diabetic Foot Ulcers","phase":"","overall_status":"TEMPORARILY_NOT_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"PolarityTE","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}